ATE291021T1 - Oxytocin agonisten - Google Patents
Oxytocin agonistenInfo
- Publication number
- ATE291021T1 ATE291021T1 AT02732974T AT02732974T ATE291021T1 AT E291021 T1 ATE291021 T1 AT E291021T1 AT 02732974 T AT02732974 T AT 02732974T AT 02732974 T AT02732974 T AT 02732974T AT E291021 T1 ATE291021 T1 AT E291021T1
- Authority
- AT
- Austria
- Prior art keywords
- oxytocin agonists
- general formula
- compounds
- agonists
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Tea And Coffee (AREA)
- Current-Collector Devices For Electrically Propelled Vehicles (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0115515.9A GB0115515D0 (en) | 2001-06-25 | 2001-06-25 | Oxytocin agonisys |
| PCT/GB2002/002872 WO2003000692A2 (en) | 2001-06-25 | 2002-06-24 | Oxytocin agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE291021T1 true ATE291021T1 (de) | 2005-04-15 |
Family
ID=9917320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02732974T ATE291021T1 (de) | 2001-06-25 | 2002-06-24 | Oxytocin agonisten |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20040235753A1 (de) |
| EP (1) | EP1399436B1 (de) |
| JP (1) | JP2005500317A (de) |
| KR (1) | KR20040010762A (de) |
| CN (1) | CN1606553A (de) |
| AT (1) | ATE291021T1 (de) |
| CA (1) | CA2450480A1 (de) |
| CZ (1) | CZ20033414A3 (de) |
| DE (1) | DE60203290T2 (de) |
| DK (1) | DK1399436T3 (de) |
| ES (1) | ES2239717T3 (de) |
| GB (1) | GB0115515D0 (de) |
| HU (1) | HUP0400368A3 (de) |
| IL (1) | IL159289A0 (de) |
| MX (1) | MXPA03011980A (de) |
| NO (1) | NO20035772L (de) |
| NZ (1) | NZ530035A (de) |
| PL (1) | PL367538A1 (de) |
| PT (1) | PT1399436E (de) |
| RU (1) | RU2309156C2 (de) |
| WO (1) | WO2003000692A2 (de) |
| ZA (1) | ZA200309626B (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4179782B2 (ja) | 2000-04-26 | 2008-11-12 | 富士通株式会社 | 無線受信装置及び無線通信システム |
| JP4615221B2 (ja) | 2002-02-27 | 2011-01-19 | フェリング ベスローテン フェンノートシャップ | ヘプタペプチドオキシトシンアナログを製造するための中間体及び方法 |
| EP1449844A1 (de) | 2003-02-14 | 2004-08-25 | Ferring B.V. | benzamidderivate als oxytocin-agonisten und vasopressin-antagonisten |
| EP1512687A1 (de) * | 2003-09-05 | 2005-03-09 | Ferring B.V. | Piperazine als Oxytocin-Agonisten |
| EP1632494A1 (de) | 2004-08-24 | 2006-03-08 | Ferring B.V. | Vasopressin v1a antagonisten |
| BRPI0617770A2 (pt) * | 2005-10-24 | 2011-08-09 | Wyeth Corp | método de tratamento de esquizofrenia ou um transtorno relacionado à esquizofrenia, ansiedade ou um transtorno relacionado à ansiedade |
| CA2685860A1 (en) * | 2007-05-10 | 2008-11-20 | Amr Technology, Inc. | Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| AR067336A1 (es) * | 2007-06-28 | 2009-10-07 | Novartis Ag | Moduladores de calicreina 7 |
| WO2009039983A2 (en) * | 2007-09-11 | 2009-04-02 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| AU2008303955A1 (en) * | 2007-09-11 | 2009-04-02 | Mondobiotech Laboratories Ag | Use of melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of Pseudomonas aeruginosa infection |
| WO2009033820A2 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| KR20100061680A (ko) * | 2007-09-11 | 2010-06-08 | 몬도바이오테크 래보래토리즈 아게 | 치료제로서의 ｇｌｙ－ｐｒｏ－ｇｌｕ－ｏｈ（ｇｐｅ）의 용도 |
| WO2009040020A1 (en) * | 2007-09-11 | 2009-04-02 | Mondobiotech Laboratories Ag | Amylin as a therapeutic agent |
| AR068509A1 (es) * | 2007-09-19 | 2009-11-18 | Jerini Ag | Antagosnistas del receptor de bradiquinina b1 |
| WO2011147889A1 (en) | 2010-05-25 | 2011-12-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical composition for the treatment of a feeding disorder with early-onset in a patient |
| GB201105537D0 (en) * | 2011-03-31 | 2011-05-18 | Vantia Ltd | New process |
| CN103159641A (zh) * | 2011-12-14 | 2013-06-19 | 天津泰普药品科技发展有限公司 | 托伐普坦中间体2-甲酸-5-(2-甲基苯甲酰氨基)甲苯的制备方法 |
| EP3226688B1 (de) * | 2014-12-05 | 2020-07-01 | Merck Sharp & Dohme Corp. | Tricyclische verbindungen als inhibitoren von mutanten idh-enzymen |
| DK3328864T3 (da) * | 2015-07-06 | 2022-12-05 | Kinoxis Therapeutics Pty Ltd | Terapeutiske forbindelser og sammensætninger til behandling af sociale forstyrrelser og stofmisbrugsforstyrrelser |
| PL3551631T3 (pl) | 2016-12-12 | 2025-03-24 | Kinoxis Therapeutics Pty Ltd | Agoniści receptora oksytocyny nie będący peptydem |
| KR20170035351A (ko) | 2017-01-06 | 2017-03-30 | 셰플러코리아(유) | 볼베어링용 케이지 |
| EP4025221A4 (de) * | 2019-09-06 | 2024-01-03 | Kinoxis Therapeutics Pty Ltd | Behandlung von opioidentzug |
| EP4378526A1 (de) * | 2022-11-30 | 2024-06-05 | Université de Strasbourg | Nicht peptiderge agonisten des oxytocinrezeptors |
| EP4378525A1 (de) * | 2022-11-30 | 2024-06-05 | Université de Strasbourg | Nicht peptiderge agonisten des oxytocinrezeptors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2665441B1 (fr) * | 1990-07-31 | 1992-12-04 | Sanofi Sa | Derives de la n-sulfonyl indoline, leur preparation, les compositions pharmaceutiques en contenant. |
| CA2358894A1 (en) * | 1999-02-04 | 2000-08-10 | American Home Products Corporation | Tricyclic pyridine n-oxides vasopressin agonists |
| GB0000079D0 (en) * | 2000-01-05 | 2000-02-23 | Ferring Bv | Novel antidiuretic agents |
| GB0015601D0 (en) * | 2000-06-26 | 2000-08-16 | Ferring Bv | Novel antidiuretic agents |
-
2001
- 2001-06-25 GB GBGB0115515.9A patent/GB0115515D0/en not_active Ceased
-
2002
- 2002-06-24 HU HU0400368A patent/HUP0400368A3/hu unknown
- 2002-06-24 CZ CZ20033414A patent/CZ20033414A3/cs unknown
- 2002-06-24 AT AT02732974T patent/ATE291021T1/de not_active IP Right Cessation
- 2002-06-24 IL IL15928902A patent/IL159289A0/xx unknown
- 2002-06-24 RU RU2003136152/04A patent/RU2309156C2/ru not_active IP Right Cessation
- 2002-06-24 KR KR10-2003-7016688A patent/KR20040010762A/ko not_active Ceased
- 2002-06-24 DK DK02732974T patent/DK1399436T3/da active
- 2002-06-24 WO PCT/GB2002/002872 patent/WO2003000692A2/en not_active Ceased
- 2002-06-24 CA CA002450480A patent/CA2450480A1/en not_active Abandoned
- 2002-06-24 NZ NZ530035A patent/NZ530035A/en unknown
- 2002-06-24 JP JP2003507095A patent/JP2005500317A/ja active Pending
- 2002-06-24 PT PT02732974T patent/PT1399436E/pt unknown
- 2002-06-24 CN CNA028125843A patent/CN1606553A/zh active Pending
- 2002-06-24 PL PL02367538A patent/PL367538A1/xx not_active Application Discontinuation
- 2002-06-24 US US10/482,102 patent/US20040235753A1/en not_active Abandoned
- 2002-06-24 EP EP02732974A patent/EP1399436B1/de not_active Expired - Lifetime
- 2002-06-24 ES ES02732974T patent/ES2239717T3/es not_active Expired - Lifetime
- 2002-06-24 MX MXPA03011980A patent/MXPA03011980A/es active IP Right Grant
- 2002-06-24 DE DE60203290T patent/DE60203290T2/de not_active Expired - Fee Related
-
2003
- 2003-12-11 ZA ZA200309626A patent/ZA200309626B/xx unknown
- 2003-12-22 NO NO20035772A patent/NO20035772L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20040010762A (ko) | 2004-01-31 |
| WO2003000692A2 (en) | 2003-01-03 |
| RU2309156C2 (ru) | 2007-10-27 |
| NO20035772L (no) | 2003-12-22 |
| HUP0400368A3 (en) | 2007-05-29 |
| WO2003000692A3 (en) | 2003-05-15 |
| IL159289A0 (en) | 2004-06-01 |
| PT1399436E (pt) | 2005-07-29 |
| US20040235753A1 (en) | 2004-11-25 |
| ES2239717T3 (es) | 2005-10-01 |
| RU2003136152A (ru) | 2005-05-20 |
| GB0115515D0 (en) | 2001-08-15 |
| MXPA03011980A (es) | 2004-03-26 |
| CN1606553A (zh) | 2005-04-13 |
| CZ20033414A3 (en) | 2004-05-12 |
| DK1399436T3 (da) | 2005-05-30 |
| CA2450480A1 (en) | 2003-01-03 |
| DE60203290T2 (de) | 2006-02-02 |
| DE60203290D1 (de) | 2005-04-21 |
| HK1064666A1 (en) | 2005-02-04 |
| HUP0400368A2 (hu) | 2004-08-30 |
| PL367538A1 (en) | 2005-02-21 |
| ZA200309626B (en) | 2004-05-12 |
| JP2005500317A (ja) | 2005-01-06 |
| EP1399436A2 (de) | 2004-03-24 |
| EP1399436B1 (de) | 2005-03-16 |
| NZ530035A (en) | 2004-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1399436T3 (da) | Oxytocinagonister | |
| IS6658A (is) | Ný efnasambönd | |
| NL300877I2 (nl) | obeticholzuur | |
| PT1263724E (pt) | Novos compostos | |
| MY127144A (en) | New anticholinergics which may be used as medicaments as well as processes for preparing them | |
| MXPA03005464A (es) | Agentes antivirales. | |
| NO20034291L (no) | 2-aminopropanolderivater | |
| WO2003016282A3 (en) | Substituted 1h-dihydropyrazoles, their preparation and use | |
| CY1107747T1 (el) | Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης | |
| MY126917A (en) | Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors | |
| AU7429001A (en) | Fused azepine derivatives and their use as antidiuretic agents | |
| WO2003016316A8 (en) | Diazacycloalkanes as oxytocin agonists | |
| SE0102055D0 (sv) | New Compounds | |
| SE0101038D0 (sv) | Novel compounds | |
| SE0003476D0 (sv) | Compounds | |
| SE9903290D0 (sv) | Novel compounds | |
| MXPA05008601A (es) | Derivados de benzamida como agonistas de oxitocina y antagonistas de vasopresina. | |
| ATE274515T1 (de) | Pyrazolopyridinderivate | |
| SE9904128D0 (sv) | Novel compounds | |
| MXPA04004450A (es) | Nuevos compuestos y composiciones como inhibidores de catepsina s. | |
| ES2183500T3 (es) | Nuevos compuestos y composiciones farmaceuticas que los contienen. | |
| NO20042729L (no) | Heksasykliske forbindelser | |
| SE9902147D0 (sv) | Nya föreningar och farmaceutiska kompositioner innehållande desamma | |
| ATE364594T1 (de) | (4-acylaminopiperidin-1-yl)acetamide als neurokininantagonisten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1399436 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |